An observational study in Immunologic Activity Alteration, sponsored by Kasr El Aini Hospital. Completed at 1 site in Egypt. Open to participants aged 25 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-06-17.
Sponsored by Kasr El Aini Hospital · Observational
To assess the seroprevalence of SARS-CoV-2 IgG in Health care workers in three University Hospitals
The proposed study is a cross sectional study that will be carried out among HCWs in three University hospitals namely Kasr Alaini , Ain Shams , and Zagazeg Hospitals, employing a quantitative survey.
II-Study population Participants will be the HCWs at great risk of getting an infection which include those who are in direct contact with respiratory secretions.
Inclusion criteria Age: From 25 to 60 years old Department: physicians and nurses from the operating room, critical care department, emergency department, pulmonology department.
The potential participants will be given an information sheet and time to review this information before informed consent is sought. After the potential participants have agreed to be enrolled in the study, an informed consent will be obtained by the Investigator.
III- Procedures and Data collection:
Serum Collection and Interview A- Detecting Serum IgG against SARS-CoV2
Blood samples will be collected from the enrolled HCWs. Sample collection, processing, and laboratory testing will follow guidance from the World Health Organization.(5) The sensitivity and specificity reported by the manufacturer for IgM are 88.2% and 99.0% respectively, and for IgG are 97.8% and 97.9%.
B- Structured Interview questionnaire
A structured - interview questionnaire using closed ended question format will be used to obtain information on:
6,687 studies on the registry are indexed under Infections; 807 are open to participants now.
This study's enrollment of 500 is above the median of 240 across 2,136 observational studies indexed under Infections.
Browse Infections studies →Kasr El Aini Hospital is the lead sponsor of 273 studies on the registry; 32 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Participants will be the HCWs at great risk of getting an infection which include those who are in direct contact with respiratory secretions.
Exclusion Criteria:
Blood samples will be collected from the enrolled HCWs. Sample collection, processing, and laboratory testing will follow guidance from the World Health Organization
Number of IGg seropositive health care workers
health care workers who have positive IGg in seum
Time frame: single measurement from each person collected over 2 months
Differentiation between low risk and high risk HCWs
to know positive IGg persons and IGg negative persons to understand risk factors
Time frame: 2 months through out duration of study
Plan to share: No
This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kasr El Aini Hospital